3 results match your criteria: "and Kaiser Permanente San Francisco Medical Center[Affiliation]"
Ann Intern Med
April 2024
Department of Cardiology, Copenhagen University Hospital - Herlev and Gentofte, and Center for Translational Cardiology and Pragmatic Randomized Trials, Department of Biomedical Sciences, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark (N.D.J., D.M., T.B.).
Background: In the NUDGE-FLU (Nationwide Utilization of Danish Government Electronic letter system for increasing inFLUenza vaccine uptake) trial, electronic letters incorporating cardiovascular (CV) gain-framing and repeated messaging increased influenza vaccination by approximately 1 percentage point.
Objective: To evaluate the effects of the successful nudging interventions on downstream clinical outcomes.
Design: Prespecified exploratory analysis of a nationwide randomized implementation trial.
Ann Intern Med
December 2018
The Permanente Medical Group and Kaiser Permanente Northern California, Oakland, and Kaiser Permanente San Rafael Medical Center, San Rafael, California (D.W.B.).
Background: Many low-risk patients with acute pulmonary embolism (PE) in the emergency department (ED) are eligible for outpatient care but are hospitalized nonetheless. One impediment to home discharge is the difficulty of identifying which patients can safely forgo hospitalization.
Objective: To evaluate the effect of an integrated electronic clinical decision support system (CDSS) to facilitate risk stratification and decision making at the site of care for patients with acute PE.
Obstet Gynecol
September 2018
Kaiser Permanente Northern California Gynecologic Cancer Program, and the Department of Obstetrics, Gynecology, and Reproductive Sciences, Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, San Francisco, Salud Para La Gente, Watsonville, Kaiser Permanente Northern California, Division of Research, Oakland, and Kaiser Permanente San Francisco Medical Center, San Francisco, California.
Objective: To estimate the rate of human papillomavirus (HPV) vaccine completion by race and ethnicity.
Methods: In this retrospective cohort study, we analyzed females aged 11-26 years who initiated HPV vaccination from 2008 through 2012 in a community-based health care system in California. Vaccine completion was defined as having received at least three injections.